PortfoliosLab logoPortfoliosLab logo
NUS vs. BLBD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NUS vs. BLBD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nu Skin Enterprises, Inc. (NUS) and Blue Bird Corporation (BLBD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NUS achieves a -45.12% return, which is significantly lower than BLBD's 58.28% return. Over the past 10 years, NUS has underperformed BLBD with an annualized return of -18.08%, while BLBD has yielded a comparatively higher 17.69% annualized return.


NUS

1D
-0.76%
1M
3.59%
6M
-50.24%
YTD
-45.12%
1Y
-34.92%
3Y*
-42.10%
5Y*
-35.06%
10Y*
-18.08%
ALL TIME*
-3.55%

BLBD

1D
-0.28%
1M
-2.22%
6M
47.86%
YTD
58.28%
1Y
71.68%
3Y*
52.13%
5Y*
24.37%
10Y*
17.69%
ALL TIME*
18.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$39.21M$34.12M$35.39M
$2.37M$2.89M$3.95M

NUS vs. BLBD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NUS
Nu Skin Enterprises, Inc.
-45.12%43.29%-63.67%-51.07%-13.92%-4.32%38.67%-30.98%-8.32%46.55%
BLBD
Blue Bird Corporation
58.28%21.67%43.29%151.73%-31.52%-14.35%-20.33%26.00%-8.59%28.80%

Correlation

The correlation between NUS and BLBD is 0.24, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.24

Correlation (3Y)
Balances recent behavior with more history.

0.27

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.27

Correlation (10Y)
Provides a long-term view across more market conditions.

0.29

Correlation (All Time)
Calculated using the full available price history since Mar 20, 2014

0.26

Fundamentals

Market Cap

NUS:

$251.98M

BLBD:

$2.35B

EPS

NUS:

$1.09

BLBD:

$4.07

PE Ratio

NUS:

4.75

BLBD:

18.27

PEG Ratio

NUS:

0.01

BLBD:

0.17

PS Ratio

NUS:

0.18

BLBD:

1.63

PB Ratio

NUS:

0.32

BLBD:

8.13

Total Revenue (TTM)

NUS:

$1.44B

BLBD:

$1.49B

Gross Profit (TTM)

NUS:

$998.90M

BLBD:

$314.22M

EBITDA (TTM)

NUS:

$115.40M

BLBD:

$181.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NUS vs. BLBD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NUS
NUS Risk / Return Rank: 1717
Overall Rank
NUS Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
NUS Sortino Ratio Rank: 1515
Sortino Ratio Rank
NUS Omega Ratio Rank: 1414
Omega Ratio Rank
NUS Calmar Ratio Rank: 2222
Calmar Ratio Rank
NUS Martin Ratio Rank: 2222
Martin Ratio Rank

BLBD
BLBD Risk / Return Rank: 8484
Overall Rank
BLBD Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
BLBD Sortino Ratio Rank: 8484
Sortino Ratio Rank
BLBD Omega Ratio Rank: 8383
Omega Ratio Rank
BLBD Calmar Ratio Rank: 8686
Calmar Ratio Rank
BLBD Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NUS vs. BLBD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nu Skin Enterprises, Inc. (NUS) and Blue Bird Corporation (BLBD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NUSBLBDDifference
Sharpe ratioReturn per unit of total volatility

-2.24

Sortino ratioReturn per unit of downside risk

-3.13

Omega ratioGain probability vs. loss probability

0.88

1.28

-0.40

Calmar ratioReturn relative to maximum drawdown

-0.60

2.83

-3.43

Martin ratioReturn relative to average drawdown

-1.03

6.36

-7.38

NUS vs. BLBD - Sharpe Ratio Comparison

The current NUS Sharpe Ratio is -0.72, which is lower than the BLBD Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of NUS and BLBD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NUS vs. BLBD - Drawdown Comparison

The maximum NUS drawdown since its inception was -94.67%, which is greater than BLBD's maximum drawdown of -74.16%. Use the drawdown chart below to compare losses from any high point for NUS and BLBD.


Loading charts...

Drawdown Indicators


NUSBLBDDifference

Max Drawdown

Largest peak-to-trough decline

-94.67%

-74.16%

-20.51%

Max Drawdown (1Y)

Largest decline over 1 year

-60.64%

-23.45%

-37.19%

Max Drawdown (3Y)

Largest decline over 3 years

-79.54%

-45.95%

-33.59%

Max Drawdown (5Y)

Largest decline over 5 years

-89.58%

-71.03%

-18.55%

Max Drawdown (10Y)

Largest decline over 10 years

-92.43%

-74.16%

-18.27%

Current Drawdown

Current decline from peak

-94.40%

-8.72%

-85.68%

Average Drawdown

Average peak-to-trough decline

-48.31%

-20.39%

-27.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.40%

10.43%

+24.97%

Volatility

NUS vs. BLBD - Volatility Comparison

Nu Skin Enterprises, Inc. (NUS) has a higher volatility of 11.80% compared to Blue Bird Corporation (BLBD) at 9.08%. This indicates that NUS's price experiences larger fluctuations and is considered to be riskier than BLBD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NUSBLBDDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.80%

9.08%

+2.72%

Volatility (6M)

Calculated over the trailing 6-month period

33.91%

32.22%

+1.69%

Volatility (1Y)

Calculated over the trailing 1-year period

50.70%

43.63%

+7.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.34%

56.47%

-9.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.11%

51.34%

-2.23%

Dividends

NUS vs. BLBD - Dividend Comparison

NUS's dividend yield for the trailing twelve months is around 4.62%, while BLBD has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BLBD
Blue Bird Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NUS
Nu Skin Enterprises, Inc.
4.62%2.49%3.48%8.03%3.65%3.00%2.75%3.61%2.38%2.11%2.97%3.69%

Financials

NUS vs. BLBD - Financials Comparison

This section allows you to compare key financial metrics between Nu Skin Enterprises, Inc. and Blue Bird Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

NUS vs. BLBD - Profitability Comparison

The chart below illustrates the profitability comparison between Nu Skin Enterprises, Inc. and Blue Bird Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

NUS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nu Skin Enterprises, Inc. reported a gross profit of 214.46M and revenue of 320.61M. Therefore, the gross margin over that period was 66.9%.

BLBD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Blue Bird Corporation reported a gross profit of 70.65M and revenue of 352.64M. Therefore, the gross margin over that period was 20.0%.

NUS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nu Skin Enterprises, Inc. reported an operating income of 4.03M and revenue of 320.61M, resulting in an operating margin of 1.3%.

BLBD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Blue Bird Corporation reported an operating income of 39.12M and revenue of 352.64M, resulting in an operating margin of 11.1%.

NUS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nu Skin Enterprises, Inc. reported a net income of 1.84M and revenue of 320.61M, resulting in a net margin of 0.6%.

BLBD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Blue Bird Corporation reported a net income of 29.30M and revenue of 352.64M, resulting in a net margin of 8.3%.


Frequently Asked Questions


NUS and BLBD have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NUS has higher volatility (11.80%) compared to BLBD (9.08%). In terms of maximum drawdown, NUS dropped -94.67% vs BLBD's -74.16%.

BLBD currently has the higher Sharpe Ratio (1.52 vs -0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NUS and BLBD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer